Literature DB >> 6092966

Biological properties of human c-Ha-ras1 genes mutated at codon 12.

P H Seeburg, W W Colby, D J Capon, D V Goeddel, A D Levinson.   

Abstract

Vertebrate genomes contain proto-oncogenes whose enhanced expression or alteration by mutation seems to be involved in the development of naturally occurring tumours. These activated genes, usually assayed by their ability to induce the malignant transformation of NIH 3T3 cells, are frequently related to the ras oncogene of Harvey (Ha-ras) or Kirsten (Ki-ras) murine sarcoma viruses, or a third member of this family (N-ras). Activation involves point mutation which often affect codon 12 (refs 16-26) of the encoded 21,000-molecular weight polypeptide (p21). To provide insight into structural requirements involved in p21 activation, we have now constructed 20 mutant c-Ha-ras1 genes by in vitro mutagenesis, each encoding a different amino acid at codon 12. Analysis of rat fibroblasts transfected with these altered genes demonstrates that all amino acids except glycine (which is encoded by normal cellular ras genes) and proline at position 12 activate p21, suggesting a requirement for an alpha-helical structure in this region of the polypeptide. The morphological phenotype of cells transformed by the activated genes can, however, depend on the particular amino acid at this position.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092966     DOI: 10.1038/312071a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  190 in total

1.  Nog2p, a putative GTPase associated with pre-60S subunits and required for late 60S maturation steps.

Authors:  C Saveanu; D Bienvenu; A Namane; P E Gleizes; N Gas; A Jacquier; M Fromont-Racine
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

2.  Characterization of KRAS rearrangements in metastatic prostate cancer.

Authors:  Xiao-Song Wang; Sunita Shankar; Saravana M Dhanasekaran; Bushra Ateeq; Atsuo T Sasaki; Xiaojun Jing; Daniel Robinson; Qi Cao; John R Prensner; Anastasia K Yocum; Rui Wang; Daniel F Fries; Bo Han; Irfan A Asangani; Xuhong Cao; Yong Li; Gilbert S Omenn; Dorothee Pflueger; Anuradha Gopalan; Victor E Reuter; Emily Rose Kahoud; Lewis C Cantley; Mark A Rubin; Nallasivam Palanisamy; Sooryanarayana Varambally; Arul M Chinnaiyan
Journal:  Cancer Discov       Date:  2011-06-01       Impact factor: 39.397

3.  An abasic site analogue activates a c-Ha-ras gene by a point mutation at modified and adjacent positions.

Authors:  H Kamiya; M Suzuki; Y Komatsu; H Miura; K Kikuchi; T Sakaguchi; N Murata; C Masutani; F Hanaoka; E Ohtsuka
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

4.  Persistence of Ha-ras-induced metastatic potential of SP1 mouse mammary tumors despite loss of the Ha-ras shuttle vector.

Authors:  B Schlatter; C G Waghorne
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

5.  Noonan syndrome: clinical aspects and molecular pathogenesis.

Authors:  M Tartaglia; G Zampino; B D Gelb
Journal:  Mol Syndromol       Date:  2010-01-15

6.  Conformational effects of amino acid substitutions at positions 10, 12, and 13 in the P21 protein.

Authors:  P W Brandt-Rauf; M R Pincus; R P Carty; J Lubowsky; M Avitable; H F Kung; J Maizel
Journal:  J Protein Chem       Date:  1989-02

7.  KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance).

Authors:  Harry H Yoon; David Tougeron; Qian Shi; Steven R Alberts; Michelle R Mahoney; Garth D Nelson; Suresh G Nair; Stephen N Thibodeau; Richard M Goldberg; Daniel J Sargent; Frank A Sinicrope
Journal:  Clin Cancer Res       Date:  2014-03-31       Impact factor: 12.531

8.  ATP-binding site of adenylate kinase: mechanistic implications of its homology with ras-encoded p21, F1-ATPase, and other nucleotide-binding proteins.

Authors:  D C Fry; S A Kuby; A S Mildvan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

9.  An attenuated phenotype of Costello syndrome in three unrelated individuals with a HRAS c.179G>A (p.Gly60Asp) mutation correlates with uncommon functional consequences.

Authors:  Karen W Gripp; Katia Sol-Church; Patroula Smpokou; Gail E Graham; David A Stevenson; Heather Hanson; David H Viskochil; Laura C Baker; Bridget Russo; Nick Gardner; Deborah L Stabley; Verena Kolbe; Georg Rosenberger
Journal:  Am J Med Genet A       Date:  2015-04-25       Impact factor: 2.802

Review 10.  Ras oncogenes: split personalities.

Authors:  Antoine E Karnoub; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.